Genome-wide association study identifies new susceptibility loci for Crohn disease and implicates autophagy in disease pathogenesis - PubMed
Comparative Study
. 2007 May;39(5):596-604.
doi: 10.1038/ng2032. Epub 2007 Apr 15.
Ramnik J Xavier, Kent D Taylor, Mark S Silverberg, Philippe Goyette, Alan Huett, Todd Green, Petric Kuballa, M Michael Barmada, Lisa Wu Datta, Yin Yao Shugart, Anne M Griffiths, Stephan R Targan, Andrew F Ippoliti, Edmond-Jean Bernard, Ling Mei, Dan L Nicolae, Miguel Regueiro, L Philip Schumm, A Hillary Steinhart, Jerome I Rotter, Richard H Duerr, Judy H Cho, Mark J Daly, Steven R Brant
Affiliations
- PMID: 17435756
- PMCID: PMC2757939
- DOI: 10.1038/ng2032
Comparative Study
Genome-wide association study identifies new susceptibility loci for Crohn disease and implicates autophagy in disease pathogenesis
John D Rioux et al. Nat Genet. 2007 May.
Abstract
We present a genome-wide association study of ileal Crohn disease and two independent replication studies that identify several new regions of association to Crohn disease. Specifically, in addition to the previously established CARD15 and IL23R associations, we identified strong and significantly replicated associations (combined P < 10(-10)) with an intergenic region on 10q21.1 and a coding variant in ATG16L1, the latter of which was also recently reported by another group. We also report strong associations with independent replication to variation in the genomic regions encoding PHOX2B, NCF4 and a predicted gene on 16q24.1 (FAM92B). Finally, we demonstrate that ATG16L1 is expressed in intestinal epithelial cell lines and that functional knockdown of this gene abrogates autophagy of Salmonella typhimurium. Together, these findings suggest that autophagy and host cell responses to intracellular microbes are involved in the pathogenesis of Crohn disease.
Figures

Single marker association results for the combined Non-Jewish and Jewish cohorts using the Cochran-Mantel-Haenszel (CMH) test. Each chromosome is depicted as a different color and the blue and red lines indicate the suggestive and significant thresholds, respectively, based on a Bonferroni correction for multiple testing. A modest correction factor (lambda 1.06-1.07) is necessary to apply in order to correct for stratification between cases and controls, but does not modify the current results.

Quantitative real-time PCR was used to determine the expression patterns of ATG5, 7 and 16L1 in a variety of human immune and epithelial cell lines. Panel A - Expression pattern of ATG5 in human cell lines. ATG5 seems broadly expressed in the cell lines studied, with between 1.5-and 4-fold variations in expression level across the cell lines. Panel B - Expression pattern of ATG7 in human cell lines. ATG7 expression levels appeared broadly comparable to those of ATG5, with the exception of THP1 cells, which exhibited a 35-fold higher level than SW480 cells. Panel C - Expression pattern of ATG16L1 in human cell lines. ATG16L1 expression was also broadly similar to those of ATG5 and 7 (with the exception of ATG7 expression in THP1 cells) with moderate variations in expression levels across the cell lines tested (1.5- to 3.5-fold). Panel D - Expression pattern of ATG16L1 in human primary immune cells. In a resting human immune cell RNA panel (Clontech, CA) ATG16L1 showed a clear peak of expression in the T cell compartment, with both CD4+ and CD8+ cells expressing high levels of transcript (15- to 20-fold more than control samples). Modest levels were detected in CD19+ cells, and low levels in CD14+ monocytes and unfractionated mononuclear cells. In all cases, real-time quantitative RTPCR reactions were performed in duplicate and the means plotted, error bars represent 1 standard deviation. Reactions containing no template RNA were performed to control for reaction contamination (water controls). Expression levels were normalized by comparison to GAPDH controls and arbitrary relative expression units plotted where SW480 or placental RNA is equal to 1 (for cell lines, or primary cells respectively). All RNAs were isolated from resting cells in the absence of stimulation or activation.

Panel A. Specific siRNA knockdown of overexpressed, Flag-tagged ATG16L1 is achieved in HEK293 cells within 48 hours of transfection with oligo duplexes. Protein levels of Flag-ATG16L1 were undetectable by Western blotting following treatment with specific siRNA constructs, but expression was maintained with control duplexes. Panel B. Endogenous ATG16L1 mRNA is efficiently knocked-down by siRNA 2 in HeLa cells within 48 hours of transfection. HeLa cells were transfected with siRNA duplexes and allowed to grow for 48 hours, RNA was then isolated and real-time quantitative RT-PCR performed. Data was normalized to GAPDH controls and siRNA control mRNA levels were set at 1.0. Compared to control duplex, siRNA 2 yielded an 89% reduction in mRNA transcript. RT-PCR reactions were performed in triplicate and means are plotted with error bars representing 1 standard deviation, results are representative of two independent experiments. Panel C. Knockdown of ATG16L1 prevents effective autophagy of S. Typhimurium in HeLa cells. 48 hours following co-transfection with control siRNA or duplex 2 and LC3-GFP plasmid, HeLa cells were infected for 1 hour with Salmonella Typhimurium SL1344, fixed and microscopically examined. The mean % of bacteria per cell encapsulated by LC3+ membranes (autophagosomes) and standard errors are shown. Bacterial counts were pooled from two separate experiments, each counting a minimum of 100 infected cells. Significance was assessed using a two-tailed Students T-test, assuming unequal variances. Panel D. Representative images of intracellular S. Typhimurium show normal autophagic encapsulation by LC3+ membranes in control siRNA-treated cells, but loss of autophagic targeting when ATG16L1 knockdown is affected. HeLa cells were transfected with LC3-GFP plasmid and siRNA and subsequently infected as decribed above. Channels are separated to show both the LC3-GFP fusion protein (autophagosomal marker) and S. Typhiumurium SL1344 dsRed2 (SL1344), with a merged image in the final column. Rows 2 and 4 show magnified views of the areas marked in rows 1 and 3 respectively. Images were obtained using confocal microscopy and are flat projection of Z-stacks taken throughout the plane of the infected cell. Scale bars represent 5 μm.
Similar articles
-
Glas J, Seiderer J, Pasciuto G, Tillack C, Diegelmann J, Pfennig S, Konrad A, Schmechel S, Wetzke M, Török HP, Stallhofer J, Jürgens M, Griga T, Klein W, Epplen JT, Schiemann U, Mussack T, Lohse P, Göke B, Ochsenkühn T, Folwaczny M, Müller-Myhsok B, Brand S. Glas J, et al. Am J Gastroenterol. 2009 Mar;104(3):665-72. doi: 10.1038/ajg.2008.65. Epub 2009 Feb 3. Am J Gastroenterol. 2009. PMID: 19262523
-
Prescott NJ, Fisher SA, Franke A, Hampe J, Onnie CM, Soars D, Bagnall R, Mirza MM, Sanderson J, Forbes A, Mansfield JC, Lewis CM, Schreiber S, Mathew CG. Prescott NJ, et al. Gastroenterology. 2007 May;132(5):1665-71. doi: 10.1053/j.gastro.2007.03.034. Epub 2007 Mar 24. Gastroenterology. 2007. PMID: 17484864
-
Confirmation of multiple Crohn's disease susceptibility loci in a large Dutch-Belgian cohort.
Weersma RK, Stokkers PC, Cleynen I, Wolfkamp SC, Henckaerts L, Schreiber S, Dijkstra G, Franke A, Nolte IM, Rutgeerts P, Wijmenga C, Vermeire S. Weersma RK, et al. Am J Gastroenterol. 2009 Mar;104(3):630-8. doi: 10.1038/ajg.2008.112. Epub 2009 Jan 27. Am J Gastroenterol. 2009. PMID: 19174780
-
ATG16L1: A multifunctional susceptibility factor in Crohn disease.
Salem M, Ammitzboell M, Nys K, Seidelin JB, Nielsen OH. Salem M, et al. Autophagy. 2015 Apr 3;11(4):585-94. doi: 10.1080/15548627.2015.1017187. Autophagy. 2015. PMID: 25906181 Free PMC article. Review.
-
Classification of genetic profiles of Crohn's disease: a focus on the ATG16L1 gene.
Grant SF, Baldassano RN, Hakonarson H. Grant SF, et al. Expert Rev Mol Diagn. 2008 Mar;8(2):199-207. doi: 10.1586/14737159.8.2.199. Expert Rev Mol Diagn. 2008. PMID: 18366306 Review.
Cited by
-
Saito M, Katsuno T, Nakagawa T, Sato T, Noguchi Y, Sazuka S, Saito K, Arai M, Yokote K, Yokosuka O. Saito M, et al. Dig Dis Sci. 2012 Aug;57(8):2022-30. doi: 10.1007/s10620-012-2133-4. Epub 2012 Mar 31. Dig Dis Sci. 2012. PMID: 22466076
-
Lidral AC, Liu H, Bullard SA, Bonde G, Machida J, Visel A, Uribe LM, Li X, Amendt B, Cornell RA. Lidral AC, et al. Hum Mol Genet. 2015 Jul 15;24(14):3895-907. doi: 10.1093/hmg/ddv047. Epub 2015 Feb 4. Hum Mol Genet. 2015. PMID: 25652407 Free PMC article.
-
Teng MW, Bowman EP, McElwee JJ, Smyth MJ, Casanova JL, Cooper AM, Cua DJ. Teng MW, et al. Nat Med. 2015 Jul;21(7):719-29. doi: 10.1038/nm.3895. Epub 2015 Jun 29. Nat Med. 2015. PMID: 26121196 Review.
-
Serum Analyte Profiles Associated With Crohn's Disease and Disease Location.
Boucher G, Paradis A, Chabot-Roy G, Coderre L, Hillhouse EE, Bitton A, Des Rosiers C, Levings MK, Schumm LP, Lazarev M, Brant SR, Duerr R, McGovern D, Silverberg MS, Cho J, Lesage S, Rioux JD; iGenoMed Consortium; NIDDK IBD Genetics Consortium. Boucher G, et al. Inflamm Bowel Dis. 2022 Jan 5;28(1):9-20. doi: 10.1093/ibd/izab123. Inflamm Bowel Dis. 2022. PMID: 34106269 Free PMC article.
-
Lee HC, Ichikawa O, Glicksberg BS, Divaraniya AA, Becker CE, Agarwal P, Dudley JT. Lee HC, et al. BioData Min. 2020 Jun 17;13:6. doi: 10.1186/s13040-020-00216-9. eCollection 2020. BioData Min. 2020. PMID: 32565911 Free PMC article.
References
-
- Loftus EV., Jr. Clinical epidemiology of inflammatory bowel disease: Incidence, prevalence, and environmental influences. Gastroenterology. 2004;126:1504–17. - PubMed
-
- Podolsky DK. Inflammatory bowel disease. N Engl J Med. 2002;347:417–29. - PubMed
-
- Halfvarson J, Bodin L, Tysk C, Lindberg E, Jarnerot G. Inflammatory bowel disease in a Swedish twin cohort: a long-term follow-up of concordance and clinical characteristics. Gastroenterology. 2003;124:1767–73. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- AI062773/AI/NIAID NIH HHS/United States
- U01 DK062432-06/DK/NIDDK NIH HHS/United States
- P30 DK040561/DK/NIDDK NIH HHS/United States
- DK62413/DK/NIDDK NIH HHS/United States
- U01 DK062413/DK/NIDDK NIH HHS/United States
- U24 DK062429/DK/NIDDK NIH HHS/United States
- DK62431/DK/NIDDK NIH HHS/United States
- U01 DK062432/DK/NIDDK NIH HHS/United States
- DK43351/DK/NIDDK NIH HHS/United States
- U01 DK062429/DK/NIDDK NIH HHS/United States
- P30 DK063491/DK/NIDDK NIH HHS/United States
- U01 DK062422/DK/NIDDK NIH HHS/United States
- P30 DK063491-029004/DK/NIDDK NIH HHS/United States
- U01 DK062423/DK/NIDDK NIH HHS/United States
- P30 DK063491-049004/DK/NIDDK NIH HHS/United States
- P01 DK046763/DK/NIDDK NIH HHS/United States
- DK62432/DK/NIDDK NIH HHS/United States
- DK62423/DK/NIDDK NIH HHS/United States
- P30 DK040561-12/DK/NIDDK NIH HHS/United States
- P30 DK043351/DK/NIDDK NIH HHS/United States
- P30 DK063491-039004/DK/NIDDK NIH HHS/United States
- DK62429/DK/NIDDK NIH HHS/United States
- DK62420/DK/NIDDK NIH HHS/United States
- DK62422/DK/NIDDK NIH HHS/United States
- DK 46763/DK/NIDDK NIH HHS/United States
- R01 AI062773/AI/NIAID NIH HHS/United States
- P30 DK063491-019004/DK/NIDDK NIH HHS/United States
- U01 DK062420/DK/NIDDK NIH HHS/United States
- U01 DK062431/DK/NIDDK NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Research Materials